Floatz logo

Omnipaque

Vaso-Occlusive Crises

University Hospital, ToursN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Vaso-Occlusive Crises cohort.

Asset / SponsorPhaseRating
Iloprost
University Hospital, Rouen
Phase 3B
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Mohsen Saidinejad
Phase 2CCC
NEPENTHE
University Hospital, Tours
N/AD

Same molecule, other indications

Omnipaque is also rated in:

Adolescent ObesityDormant
CCC
Indicative ·
52 / 100
View asset →
Diabetic Kidney DiseaseDormant
CCC
Indicative ·
52 / 100
View asset →
Diabetes ComplicationsDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →